Understanding exacerbation risk in BLVR: A logistic regression approach to complication prediction
Chronic Respiratory Disease · 2026-04 · 23
DOI: 10.1177/14799731261443319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chronic Respiratory Disease, online erschienen am 22.04.2026. Verfasst von Johannes Wienker und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Division of Interventional Pneumology, University Medicine Essen-Ruhrlandklinik, Essen, Germany. Hauptthemen laut MEDLINE: Pulmonary Emphysema, Pulmonary Disease, Chronic Obstructive, Bronchoscopy, Pneumonectomy. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chronic obstructive pulmonary disease (COPD) with emphysema is associated with persistent airflow limitation and frequent exacerbations. Bronchoscopic lung volume reduction (BLVR) with endobronchial valves (EBVs) improves lung function and quality of life but carries a risk of postprocedural complications, including acute exacerbations and pneumonia. Predictors of these adverse events remain incompletely defined.
Purpose
To identify clinical and inflammatory factors associated with postprocedural exacerbations in patients undergoing BLVR with EBVs, aiming to support individualized risk stratification. Patients and Methods We retrospectively analyzed 320 patients with advanced emphysema treated with EBVs between 2015 and 2022. Patients underwent comprehensive preprocedural evaluation, including pulmonary function testing, imaging, perfusion scintigraphy, 6-minute walk test and COPD Assessment Test. Postprocedural exacerbations within 8 weeks were documented clinically and radiographically. Binary logistic regression, including multivariable modeling, was used to identify independent predictors.
Results
Thirty-five patients (10.9%) developed post-BLVR exacerbations, six of whom had pneumonia. Exacerbation risk was independently associated with diabetes mellitus type II (OR 11.0, p < 0.001), elevated C-reactive protein >1 mg/dL (OR 9.35, p < 0.001), WBC >11 cells/nL (OR 5.46, p = 0.002), prior exacerbation frequency (OR 2.94, p < 0.001) and low BMI (OR 0.78, p < 0.001). Residual volume showed a trend toward significance ( p = 0.058). The final model demonstrated excellent discriminative ability (AUC = 0.923). While lung function improvement was attenuated in the exacerbation group, quality of life gains were comparable.
Conclusion
Elevated inflammatory markers, diabetes, frequent prior exacerbations and low BMI were independently associated with early postprocedural exacerbations following BLVR with EBVs. Comprehensive preprocedural assessment and targeted management of these risk factors may enhance patient safety and improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Division of Interventional Pneumology, University Medicine Essen-Ruhrlandklinik, Essen, Germany.
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
- Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
- Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital Essen, Essen, Germany.
- Department of Emergency Medicine, University Hospital Essen, Essen, Germany.
- Department of Pulmonary Medicine, University Medicine Essen-Ruhrlandklinik, Essen, Germany.
ORCID-Profile: Johannes Wienker, Kaid Darwiche, Lukas van de Sand
Zitieren
APA
Wienker, J., Darwiche, K., Karpf-Wissel, R., Büscher, E., Haubold, J., Kersting, D., Hautzel, H., van de Sand, L., Kassem, A., Mersmann, K., Taube, C., Opitz, M., & Struß, M. (2026). Understanding exacerbation risk in BLVR: A logistic regression approach to complication prediction. Chronic Respiratory Disease, 23. https://doi.org/10.1177/14799731261443319
Vancouver
Wienker J, Darwiche K, Karpf-Wissel R, Büscher E, Haubold J, Kersting D, et al. Understanding exacerbation risk in BLVR: A logistic regression approach to complication prediction. Chronic Respiratory Disease. 2026;23. doi:10.1177/14799731261443319
BibTeX
@article{Wienker2026,
author = {Wienker, Johannes and Darwiche, Kaid and Karpf-Wissel, Rüdiger and Büscher, Erik and Haubold, Johannes and Kersting, David and Hautzel, Hubertus and van de Sand, Lukas and Kassem, Aymen and Mersmann, Kristin and Taube, Christian and Opitz, Marcel and Struß, Marc},
title = {Understanding exacerbation risk in BLVR: A logistic regression approach to complication prediction},
journal = {Chronic Respiratory Disease},
year = {2026},
volume = {23},
doi = {10.1177/14799731261443319}
}
EUVIMED